← Back
$LXEO All transactions

Lexeo Therapeutics, Inc.

▼ SELL

$ Value

$7K

Shares

721

Price

$9

Filed

Feb 20

Insider

Name

Otero Jose Manuel

Title

Chief Operating Officer

CIK

0002024096

Roles

Officer

Transaction Details

Transaction Date

2025-11-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

63,476

Footnotes

On November 20, 2025, the reporting person filed a Form 4 which inadvertently reported that a sale to cover tax obligations occurred on August 18, 2025. In fact, as reported in this amendment, the sale occurred on November 18, 2025. | Represents a sale to cover tax obligations on the release of restricted stock units ("RSUs"). | This transaction was executed in multiple trades at prices ranging from $9.09 to $9.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. | Includes 47,733 RSUs.

Filing Info

Accession No.

0002024096-26-000004

Form Type

4/A

Issuer CIK

0001907108

Otero Jose Manuel's History

Date Ticker Type Value
2026-02-18 LXEO $19K
2026-02-04 LXEO A $0
2026-02-04 LXEO A $0
2025-11-18 LXEO $7K
2025-10-17 LXEO $19K
2025-10-17 LXEO $229
2025-10-15 LXEO A $0
2025-08-18 LXEO $13K
2025-08-18 LXEO $7K

Other Insiders at LXEO (90d)

Insider Bought Sold Last
Townsend Richard Nolan
Chief Executive Officer
$378K 2026-04-06
Otero Jose Manuel
Chief Operating Officer
$19K 2026-02-18
Tamayo Louis Edward
Chief Financial Officer
2026-02-04
Bhalla Narinder Pal
Chief Medical Officer
2026-02-13